PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsOsteoporosis drug touted as potential 'BRCA-blocker'

BioNews

Osteoporosis drug touted as potential 'BRCA-blocker'

Published 28 June 2016 posted in News and appears in BioNews 857

Author

Jonathan Bestwick

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

A drug currently used to treat osteoporosis in old age may help prevent breast cancer in women with a genetic predisposition for the disease...

A drug currently used to treat osteoporosis in old age may help prevent breast cancer in women with a genetic predisposition for the disease.

While still at a preliminary stage, the study found that the drug denosumab could 'switch off' the growth of cancer precursor cells in BRCA1-mutant breast tissue – a result that the researchers now hope to confirm in human clinical trials.

'This is potentially a very important discovery for women who carry a faulty BRCA1 gene,' said Professor Geoffrey Lindeman, whose lab at the Walter and Eliza Hall Institute in Melbourne carried out the research.

Women who carry BRCA1 mutations are at a high risk of developing breast and ovarian cancers. Carriers of the faulty gene can choose to undergo surgical removal of their breast tissue and ovaries to reduce the likelihood of developing the disease but, apart from regular screening, no other preventative approaches are currently available.

'We were interested in finding an alternative option, a non-surgical approach for these women,' said Emma Nolan, first author on the study, which was published in Nature Medicine.

In breast tissue samples provided by women with a mutated BRCA1 gene, the team identified cancer precursor cells that had properties that were very similar to aggressive breast cancer cells.

'These cells proliferated rapidly, and were susceptible to damage of their DNA – both factors that help them transition towards cancer,' said Nolan.

Importantly, the team also found that these cells could be identified by the presence of a marker protein called RANK on their surface.

The protein, which plays a role in cell growth, is inhibited by denosumab, a drug currently used to treat osteoporosis and breast cancer that has spread to the bone. By inhibiting RANK in BRCA1-mutated breast tissue, the researchers found that development of breast cancer was significantly curtailed.

Subsequent experiments in mice with BRCA1 mutations also slowed the development of breast cancer tumours.

'We are very excited by these findings because it means we've found a strategy that might be useful to prevent breast cancer in very high-risk women,' said Professor Lindeman.

It is hoped that these lab-based findings will translate to clinical trials. Further research is also needed to investigate implications of the long-term use of denosumab, which is already known to have side effects.

'[Nonetheless] when weighted against the potential for delaying cancer progression in high risk women, it is a worthy area for future work,' said Dr Jason Carroll, a Cancer Research UK scientist not involved in the study.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
20 June 2017 • 2 minutes read

Cancer-causing effect of common chemical pinpointed

by Shaoni Bhattacharya

A common chemical found in household products could increase the risk of cancer by blocking the ability of cells to fix genetic flaws which lead to the disease...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
19 July 2016 • 3 minutes read

BRCA mutations linked to prostate and uterine cancers

by Dr Antony Starza-Allen

Genetic mutations on several genes including BRCA2 have been associated with prostate cancer; while in a separate study, a BRCA1 mutation has been linked to a particular form of uterine cancer...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
6 June 2016 • 2 minutes read

BRCA database now holds data on 6200 variants

by Dr Jamie Heather

After one year of existence, the BRCA Share database has released details on its progress in collating information on variants of the BRCA1 and BRCA2 genes...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
6 May 2016 • 3 minutes read

More young women with cancer having BRCA testing

by Jonathan Bestwick

More than 95 percent of younger women diagnosed with early-onset breast cancer are opting for genetic testing, a study has found...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
25 April 2016 • 2 minutes read

BRCA1 mutation linked to reduced egg reserves

by Dr Katie Howe

Women with a mutation in the breast-cancer susceptibility gene BRCA1 may have reduced numbers of eggs left in their ovaries, according to a study led by Australian scientists...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
12 October 2015 • 2 minutes read

BRCA gene cannot be patented, says Australia's High Court

by Cait McDonagh

An isolated gene sequence cannot be patented, Australia's highest court has unanimously ruled. It is the latest and final decision in litigation that has lasted over five years...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Genes guide A-level choices 'more than environment'

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856